Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Dec;86(6):886-91.
doi: 10.1016/0029-7844(95)00257-r.

Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine

C Hocke  1 , P Morlat, G Chene, L Dequae, F Dabis
Affiliations
Comparative Study

Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine

C Hocke et al. Obstet Gynecol. 1995 Dec.

Abstract

Objective: To study the prognostic role of pregnancy on the progression of human immunodeficiency virus (HIV) infection.

Methods: In a prospective cohort study at the Bordeaux University Hospital, France, 57 women who completed a pregnancy during the course of their HIV infection were compared with 114 HIV-infected women who never conceived. The two groups were matched on CD4 lymphocyte count (CD4), age, and year of HIV diagnosis. The main outcome measures were death, occurrence of a first AIDS-defining event, and drop of the CD4 below 200/mm3.

Results: The mean follow-up period in pregnant women was 61 months from HIV diagnosis (median CD4 at entry 455/mm3) and 54 months from beginning of pregnancy. Nonpregnant women were followed-up for 50 months since HIV diagnosis (median CD4 460/mm3). The proportion of asymptomatic women at entry in the study was 51 of 57 (90%) in pregnant and 87 of 114 (76%) in nonpregnant women. No significant difference was observed between the two groups with regard to the different end points studied, even after adjustment for other prognostic variables. Adjusted hazard ratios (pregnant/nonpregnant) were 0.92 for death (95% confidence interval [CI] 0.40-2.12), 1.02 for occurrence of a first AIDS-defining event (95% CI 0.48-2.18), and 1.20 for drop of the CD4 to less than 200/mm3 (95% CI 0.63-2.27).

Conclusion: In a cohort of HIV-infected women with mild to moderate immunosuppression, pregnancy did not accelerate progression to AIDS or death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Probability of survival in pregnant and nonpregnant human immunodeficiency virus–seropositive women.
Figure 2
Figure 2
AIDS-free survival curve in pregnant and nonpregnant human immunodeficiency virus–seropositive women.
Figure 3
Figure 3
Probability of not reaching a CD4 count less than 200/mm3 in pregnant and nonpregnant human immunodeficiency virus–seropositive women.
See this image and copyright information in PMC

References

    1. Mandelbrot L, Henrion R. Does pregnancy accelerate disease progression in HIV-infected women? In: Johnson MA, Johstone FD, editors. HIV infection in women. Edinburgh: Churchill Livingstone; 1993. pp. 157–71.
    1. Scott GB, Fischl MA, Klimas N, Fletcher MA, Dickinson GM. Mothers of infants with the acquired immunodeficiency syndrome. JAMA. 1985;253:363–6. - PubMed
    1. Minkoff H, Nanda D, Menez R, Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: Follow-up of mothers, children, and subsequently born siblings. Obstet Gynecol. 1987;69:288–91. - PubMed
    1. Lindgren S, Anzen B, Bohlin AB, Lidman K. HIV and childbearing: Clinical outcome and aspects of mother to infant transmission. AIDS. 1991;5:1111–6. - PubMed
    1. Schafer A. The effects of pregnancy on the natural evolution of HIV infection. The experience of Berlin. In: Berrebi, editor. HIV infection in mother and child. Paris: Privat; 1988. pp. 127–47.

Publication types

LinkOut - more resources